Skip to main content
. 2023 Mar 28;141(25):3109–3121. doi: 10.1182/blood.2022019359

Table 1.

Diffraction data collection and phasing and refinement statistics for lufaxin

Crystal parameters Lufaxin-Br Lufaxin
Accession numbers PDB:8EO2
Resolution (Å) 36-3.48 42-2.31
Beamline 22-ID 22-ID
Wavelength (Å) 0.9184 1.0000
Completeness (total/high resolution shell) 99.5/100.0 100.0/100.0
Average redundancy (total/high resolution shell) 3.60/3.70 8.7/8.0
Rmerge (total/high resolution shell, %) 3.9/5.7 5.7/55.3
CC1/2 0.99/0.99 0.99/0.94
I/sigI (total/high resolution shell) 19.8/4.00 21.5/4.12
Observed reflections 68 510 302 907
Unique reflections 18 896 34 638
Space group P212121 P212121
Unit cell dimensions (Å)
 a 64.55 64.48
 b 71.34 71.31
 c 167.37 167.32
α, β, γ (°) 90 90
No. of Br sites 14
FOM (phenix.autosol) 0.29
Refinement Lufaxin model
Total non H protein atoms 4493
Total non H solvent atoms 143
RMS deviations
 Bond lengths (Å) 0.008
 Bond angles (°) 0.90
Mean B factors (Å2)
 Protein 60.1
 Solvent 52.6
Molprobity analysis
 Ramachandran plot (favored/allowed, %) 93.9/100
 Clashscore 4.00
 Rotamer outliers (%) 0.80
Rcryst/Rfree 0.20/0.25

Br, bromide ion; CC1/2, correlation coefficient 1/2; FOM, figure of merit; RMS, root mean squared.